J Clin Oncol 2013 May 1
Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.
Related Questions
What factors determine the choice of treatment in the management of intermediate (BCLC stage B) hepatocellular carcinoma?
1 Answers
Mednet MemberInvited Expert
Radiation Oncology · Mayo Clinic Rochester
For Stage B disease, the major factors that I use to determine treatment (we discuss all such cases at our institutional multidisciplinary liver tumor board) are performance status, Child Pugh score/liver function, and the extent of disease. If patients have PS 0-2 and are CPA/B7, these patients may...
What is your treatment algorithm for solitary hepatocellular carcinoma, 3-5 cm, non-operative candidate but Child-Turcotte Pugh A/B?
1
1 AnswersMednet MemberInvited Expert
Radiation Oncology · Mayo Clinic Rochester
This really boils down to two issues: CTP score and size of the lesion. For patients who are CTPA with a lesion <3 cm, RFA/MWA or SBRT are good options although there is some data from the University of Michigan (Wahl et al., JCO 2014) that lesions > 2 cm are better served with SBRT. For solitary le...